NEW YORK (GenomeWeb) – Guardant Health said today that Medicare contractor Palmetto GBA has finalized its local coverage determination for the Guardant360 liquid biopsy assay in non-small cell lung cancer.
...and receive Daily News bulletins.
Already have an account?Login Now.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.